Prime Minister Benjamin Netanyahu's political survival hinges on his coalition's narrow Knesset majority amid polls showing Likud steady at 25 seats and the bloc short of 61, while opposition parties lack one seat for a government without Arab support ahead of scheduled October 27, 2026 legislative elections. Recent disclosure of his successful 2024 prostate cancer treatment, previously undisclosed for security reasons, neutralizes health speculation. Corruption trial testimony faces repeated delays due to Iran and Lebanon ceasefires, with Netanyahu accusing Hezbollah of truce sabotage yesterday. Coalition tensions persist over judicial overhaul bills and haredi draft exemptions, but March budget passage averted snap election; fragile de-escalation could shift trader odds on early exit.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · AktualisiertNetanjahu raus bis...?
Netanjahu raus bis...?
$118,470,358 Vol.
30. April
<1%
30. Juni
6%
31. Dezember
44%
$118,470,358 Vol.
30. April
<1%
30. Juni
6%
31. Dezember
44%
An announcement of Benjamin Netanyahu's resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Benjamin Netanyahu and the government of Israel; however, a consensus of credible reporting may also be used.
Markt eröffnet: Mar 18, 2026, 7:57 PM ET
Resolver
0x65070BE91...An announcement of Benjamin Netanyahu's resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Benjamin Netanyahu and the government of Israel; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...Prime Minister Benjamin Netanyahu's political survival hinges on his coalition's narrow Knesset majority amid polls showing Likud steady at 25 seats and the bloc short of 61, while opposition parties lack one seat for a government without Arab support ahead of scheduled October 27, 2026 legislative elections. Recent disclosure of his successful 2024 prostate cancer treatment, previously undisclosed for security reasons, neutralizes health speculation. Corruption trial testimony faces repeated delays due to Iran and Lebanon ceasefires, with Netanyahu accusing Hezbollah of truce sabotage yesterday. Coalition tensions persist over judicial overhaul bills and haredi draft exemptions, but March budget passage averted snap election; fragile de-escalation could shift trader odds on early exit.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · Aktualisiert
Vorsicht bei externen Links.
Vorsicht bei externen Links.
Häufig gestellte Fragen